BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23088419)

  • 1. Simple and accurate bedside diagnostic kit for determining haemophilia A and B: a revised version.
    Sasanakul W; Kadegasem P; Chaiyaratana W; Wongwerawattanakoon P; Sirachainan N; Chuansumrit A
    Haemophilia; 2013 Jan; 19(1):e48-9. PubMed ID: 23088419
    [No Abstract]   [Full Text] [Related]  

  • 2. Accurate bedside diagnostic kit for determining haemophilia A and B.
    Chuansumrit A; Pongtanakul B; Kadegasem P; Sasanakul W; Chotsupakarn S; Kitpoka P; Wongwerawattanakoon P; Bejrachandra S
    Haemophilia; 2009 Jan; 15(1):361-4. PubMed ID: 18700843
    [No Abstract]   [Full Text] [Related]  

  • 3. A simple inhibitor screen is more sensitive than a Bethesda assay in monitoring for the development of inhibitors in haemophilia A and B.
    Keeling D; Beavis J; Sukhu K
    Br J Haematol; 2005 Mar; 128(6):885. PubMed ID: 15755295
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent advances in the detection of carriers of haemophilia A, B and Von Willebrand's disease.
    Schinco PM; Rizza CR
    Haematologica; 1983; 68(1):124-34. PubMed ID: 6404703
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial: Haemophilia in women.
    Lancet; 1973 Dec; 2(7841):1305-6. PubMed ID: 4127650
    [No Abstract]   [Full Text] [Related]  

  • 6. [Possibilities of detection of haemophilia carriers (author's transl)].
    Marbet GA; Marbet B; Duckert F
    Ther Umsch; 1979 Apr; 36(4):334-40. PubMed ID: 451952
    [No Abstract]   [Full Text] [Related]  

  • 7. Fetal factor VIII and IX levels in early pregnancy and their significance in prenatal diagnosis.
    Fortune WA; Cox JR
    Acta Haematol; 1973; 49(5):314-7. PubMed ID: 4198913
    [No Abstract]   [Full Text] [Related]  

  • 8. Requiem to prenatal diagnosis of haemophilia A and B using coagulation activity and antigen based assays: not yet!
    Shetty S; Ghosh K; Anbhavne S; Mohanty D
    Eur J Haematol; 2003 Apr; 70(4):253-4. PubMed ID: 12656753
    [No Abstract]   [Full Text] [Related]  

  • 9. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO).
    Hay CR; Baglin TP; Collins PW; Hill FG; Keeling DM
    Br J Haematol; 2000 Oct; 111(1):78-90. PubMed ID: 11091185
    [No Abstract]   [Full Text] [Related]  

  • 10. [Characteristics of the diagnosis, clinical aspects and treatment of hemophilias with specific, circulating anticoagulants].
    Barkagan ZS; Sukhoveeva EIa; Eremin GF; Tolochko OI; Shevchenko VI
    Probl Gematol Pereliv Krovi; 1972 Apr; 17(4):35-41. PubMed ID: 4680852
    [No Abstract]   [Full Text] [Related]  

  • 11. [An unified method of one-stage quantitative analysis of factors VIII and IX. I. (Results of the studies of the working group of the All-Union Problem-Solving Commission on "Pathology of hemostasis")].
    Barkagan ZS
    Gematol Transfuziol; 1991 Apr; 36(4):33-5. PubMed ID: 1906034
    [No Abstract]   [Full Text] [Related]  

  • 12. The comparison of CS-2500 and BCS XP coagulation analyzers for Factor VIII and Factor IX one-stage clotting assays.
    Genc S; Aydin AF; Karaca E; Ömer B
    Int J Lab Hematol; 2019 Oct; 41(5):e124-e127. PubMed ID: 31034727
    [No Abstract]   [Full Text] [Related]  

  • 13. Prenatal diagnosis of hemophilia by fetal blood sampling under ultrasound guidance.
    Forestier F; Daffos F; Solé Y; Rainaut M
    Haemostasis; 1986; 16(5):346-51. PubMed ID: 3096842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the care and treatment of children with hemophilia.
    Manco-Johnson MJ
    Adv Pediatr; 2010; 57(1):287-94. PubMed ID: 21056743
    [No Abstract]   [Full Text] [Related]  

  • 15. [Molecular diagnosis in patients and carriers of hemophilia A and B].
    Mantilla-Capacho J; Beltrán-Miranda CP; Jaloma-Cruz AR
    Gac Med Mex; 2005; 141(1):69-71. PubMed ID: 15754755
    [No Abstract]   [Full Text] [Related]  

  • 16. [Genetic diagnosis in haemophiliacs (haemophilia A, B, carrier)].
    Mikami S
    Rinsho Byori; 1990 Jun; Suppl 85():102-13. PubMed ID: 1976834
    [No Abstract]   [Full Text] [Related]  

  • 17. [Genetic factors in hemophilia].
    Rozynkowa D
    Acta Haematol Pol; 1987; 18(1-2):96-100. PubMed ID: 3124485
    [No Abstract]   [Full Text] [Related]  

  • 18. Trypsin clotting time (K-test) in hemophilia A and in hemophilia B1.
    Girolami A; Dal Bo Zanon R; Procidano M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):863-71. PubMed ID: 6176512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current laboratory practices in the diagnosis and management of haemophilia: a global assessment.
    Kitchen S; Signer-Romero K; Key NS
    Haemophilia; 2015 Jul; 21(4):550-7. PubMed ID: 25688866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of stanozolol on factors VIII and IX and serum aminotransferases in haemophilia.
    Greer IA; Greaves M; Madhok R; McLoughlin K; Porter N; Lowe GD; Preston FE; Forbes CD
    Thromb Haemost; 1985 Jun; 53(3):386-9. PubMed ID: 3931287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.